The store will not work correctly when cookies are disabled.
N-(4-acetyl-5-ethyl-5-propyl-4,5-dihydro-1,3,4-thiadiazol-2-yl)acetamide
ID: ALA4295112
PubChem CID: 145994133
Max Phase: Preclinical
Molecular Formula: C11H19N3O2S
Molecular Weight: 257.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCCC1(CC)SC(NC(C)=O)=NN1C(C)=O
Standard InChI: InChI=1S/C11H19N3O2S/c1-5-7-11(6-2)14(9(4)16)13-10(17-11)12-8(3)15/h5-7H2,1-4H3,(H,12,13,15)
Standard InChI Key: PIEHGFXRLKUNES-UHFFFAOYSA-N
Molfile:
RDKit 2D
17 17 0 0 0 0 0 0 0 0999 V2000
22.2301 -15.6227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8697 -15.1145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1097 -14.8146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5316 -15.6007 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
24.1964 -15.1254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9476 -14.3443 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1313 -14.3429 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.9719 -15.3831 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.5828 -14.8403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3583 -15.0980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4183 -14.0399 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.6541 -13.6794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9901 -12.9345 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.8410 -13.7609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3518 -16.4260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4699 -15.3230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7132 -16.9360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
2 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 2 1 0
5 8 1 0
8 9 1 0
9 10 1 0
9 11 2 0
7 12 1 0
12 13 2 0
12 14 1 0
15 1 1 0
3 16 1 0
15 17 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 257.36 | Molecular Weight (Monoisotopic): 257.1198 | AlogP: 1.90 | #Rotatable Bonds: 3 |
Polar Surface Area: 61.77 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.69 | CX Basic pKa: 0.02 | CX LogP: 1.80 | CX LogD: 1.80 |
Aromatic Rings: ┄ | Heavy Atoms: 17 | QED Weighted: 0.84 | Np Likeness Score: -0.79 |
References
1. Talapatra SK, Tham CL, Guglielmi P, Cirilli R, Chandrasekaran B, Karpoormath R, Carradori S, Kozielski F.. (2018) Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors., 156 [PMID:30031975] [10.1016/j.ejmech.2018.07.006] |